TY - JOUR
T1 - Arabinitol enantiomers in cerebrospinal fluid
AU - Christensson, Bertil
AU - Roboz, John
N1 - Funding Information:
AcknowledgementSsp eciatl hanksa redue to Brian Wong,M .D., Div. InfectiousD iseasesD, ept.Int. Medicine,U niv. CincinnatCi ol-lege of Medicine, Cincinnati,O hio for helpingw ith the positive identificatioonf I>arabinitoinl CSF usingh is D-arabinitodl ehydro-genasee nzymep reparationT.h is work was supportedb y a grant from the Dept. Healtha ndH umanS ervice(sC A40050-01a)n dby the T.J. Martell MemorialF oundationfo r LeukemiaC, ancera ndAIDS ResearchF. inanciasl upportf or Dr. Christenssowna s givenb y The Swedish Medical ResearchC ouncil (K89-16H-8818,8 805-01)a nd The SwedishS ocietyo f Medicine.
PY - 1991/10
Y1 - 1991/10
N2 - d-Arabinitol is a metabolite of Candida species, and its presence in serum above endogenous concentration may indicate disseminated candidiasis. The o-trifluoroacetylated derivatives of arabinitol enantiomers in cerebrospinal fluid (CSF) were separated using perpentylated cyclodextrin capillary columns and measured by selected ion monitoring using negative chemical ionization mass spectrometry. The presence of d-arabinitol was confirmed using highly specific d-arabinitol dehydrogenase. The mean d l-arabinitol ratio, 16.7 ± 4.8 (range: 8.6-22.8), in CSF of the "controls" is approximately 10-fold higher than the ratio previously found in normal serum and urine. At the same time, the mean l-arabinitol concentration, 0.13 ± 0.05 (range: 0.09-0.2), is virtually identical to that in serum. Therefore, the high d l-arabinitol ratio in CSF is attributed to d-arabinitol. Persistently high d l ratios were found in a variety of diseases (without Candida infection). The finding of d-arabinitol in CSF suggests that serum d-arabinitol may originate from the brain or the spinal cord, rather than from resident Candida species in the gut, and that the accumulation of d-arabinitol in CSF may be caused by non-consumption or, conversely, the high concentration may be maintained in order to have it readily available for metabolism in the brain.
AB - d-Arabinitol is a metabolite of Candida species, and its presence in serum above endogenous concentration may indicate disseminated candidiasis. The o-trifluoroacetylated derivatives of arabinitol enantiomers in cerebrospinal fluid (CSF) were separated using perpentylated cyclodextrin capillary columns and measured by selected ion monitoring using negative chemical ionization mass spectrometry. The presence of d-arabinitol was confirmed using highly specific d-arabinitol dehydrogenase. The mean d l-arabinitol ratio, 16.7 ± 4.8 (range: 8.6-22.8), in CSF of the "controls" is approximately 10-fold higher than the ratio previously found in normal serum and urine. At the same time, the mean l-arabinitol concentration, 0.13 ± 0.05 (range: 0.09-0.2), is virtually identical to that in serum. Therefore, the high d l-arabinitol ratio in CSF is attributed to d-arabinitol. Persistently high d l ratios were found in a variety of diseases (without Candida infection). The finding of d-arabinitol in CSF suggests that serum d-arabinitol may originate from the brain or the spinal cord, rather than from resident Candida species in the gut, and that the accumulation of d-arabinitol in CSF may be caused by non-consumption or, conversely, the high concentration may be maintained in order to have it readily available for metabolism in the brain.
KW - Arabinitol enantiomer separation
KW - Cerebrospinal fluid
KW - GC-MS
KW - Negative chemical ionization
KW - d l-Arabinitol ratio
KW - d-Arabinitol
KW - l-Arabinitol
UR - https://www.scopus.com/pages/publications/0026005937
U2 - 10.1016/0022-510X(91)90150-6
DO - 10.1016/0022-510X(91)90150-6
M3 - Article
C2 - 1757799
AN - SCOPUS:0026005937
SN - 0022-510X
VL - 105
SP - 234
EP - 239
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
IS - 2
ER -